IFN-γ production dominates the early human natural killer cell response to Coxsackievirus infection

Cellular Microbiology

Volumn 10, Issue 2, 2008, Pages 426-436

  Hühn, Michael H ^a   Hultcrantz, Monica ^a   Lind, Katharina ^a   Ljunggren, Hans Gustaf ^a   Malmberg, Karl Johan ^a   Flodström Tullberg, Malin ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COAT PROTEIN; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; GENOMIC RNA; HLA ANTIGEN CLASS 1; MESSENGER RNA; SINGLE STRANDED RNA; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; ASEPTIC MENINGITIS; AUTOIMMUNE DISEASE; CELL CULTURE; CELLULAR IMMUNITY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; DOWN REGULATION; ENTEROVIRUS; ENTEROVIRUS INFECTION; FLOW CYTOMETRY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INTERFERON PRODUCTION; LYMPHOCYTE FUNCTION; MOUSE; MYOCARDITIS; NATURAL KILLER CELL; NONHUMAN; PANCREATITIS; PATHOGENESIS; PICORNAVIRUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STAINING; VIRUS EXPRESSION; VIRUS INDUCTION; VIRUS MYOCARDITIS; VIRUS REPLICATION;

CAPSID PROTEINS; COXSACKIEVIRUS INFECTIONS; DOWN-REGULATION; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE II; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LIGANDS; RECEPTORS, IMMUNOLOGIC;

COXSACKIEVIRUS; MUS;

EID: 38049134286     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2007.01056.x     Document Type: Article

References (68)

1. Alter, G., Malenfant, J.M., and Altfeld, M. (2004) CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294: 15-22.
2. Andoniou, C.E., Andrews, D.M., and Degli-Esposti, M.A. (2006) Natural killer cells in viral infection: More than just killers. Immunol Rev 214: 239-250.
3. Arnon, T.I., Markel, G., and Mandelboim, O. (2006) Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol 16: 348-358.
4. Bedard, K.M., and Semler, B.L. (2004) Regulation of picornavirus gene expression. Microbes Infect 6: 702-713.
5. Bradley, M., Zeytun, A., Rafi-Janajreh, A., Nagarkatti, P.S., and Nagarkatti, M. (1998) Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas-tumor cells. Blood 92: 4248-4255.
6. Brilot, F., Geenen, V., Hober, D., and Stoddart, C.A. (2004) Coxsackievirus B4 infection of human fetal thymus cells. J Virol 78: 9854-9861.
7. Carthy, C.M., Granville, D.J., Watson, K.A., Anderson, D.R., Wilson, J.E., Yang, D., etal. (1998) Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J Virol 72: 7669-7675.
8. Chehadeh, W., Kerr-Conte, J., Pattou, F., Alm, G., Lefebvre, J., Wattre, P., and Hober, D. (2000) Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol 74: 10153-10164.
9. Chehadeh, W., Bouzidi, A., Alm, G., Wattre, P., and Hober, D. (2001) Human antibodies isolated from plasma by affinity chromatography increase the coxsackievirus B4-induced synthesis of interferon-alpha by human peripheral blood mononuclear cells in vitro. J Gen Virol 82: 1899-1907.
10. Chesler, D.A., and Reiss, C.S. (2002) The role of IFN-gamma in immune responses to viral infections of the central nervous system. Cytokine Growth Factor Rev 13: 441-454.
11. Choe, S.S., Dodd, D.A., and Kirkegaard, K. (2005) Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology 337: 18-29.
12. Cohen, G.B., Gandhi, R.T., Davis, D.M., Mandelboim, O., Chen, B.K., Strominger, J.L., and Baltimore, D. (1999) The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10: 661-671.
13. Cornell, C.T., Kiosses, W.B., Harkins, S., and Whitton, J.L. (2006) Inhibition of protein trafficking by coxsackievirus b3: Multiple viral proteins target a single organelle. J Virol 80: 6637-6647.
14. Cornell, C.T., Kiosses, W.B., Harkins, S., and Whitton, J.L. (2007) Coxsackievirus b3 proteins directionally complement each other to downregulate surface major histocompatibility complex class I. J Virol 81: 6785-6797.
15. Dotta, F., Censini, S., van Halteren, A.G., Marselli, L., Masini, M., Dionisi, S., etal. (2007) Coxsackie B4 virus infection of {beta} cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA 104: 5115-5120.
16. Eriksson, U., Kurrer, M.O., Sebald, W., Brombacher, F., and Kopf, M. (2001) Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: Induction by IL-12 and protection by IFN-gamma. J Immunol 167: 5464-5469.
17. Flodstrom, M., Maday, A., Balakrishna, D., Cleary, M.M., Yoshimura, A., and Sarvetnick, N. (2002) Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 3: 373-382.
18. Flodstrom-Tullberg, M., Hultcrantz, M., Stotland, A., Maday, A., Tsai, D., Fine, C., etal. (2005) RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J Immunol 174: 1171-1177.
19. Gasser, S., and Raulet, D.H. (2006a) Activation and self-tolerance of natural killer cells. Immunol Rev 214: 130-142.
20. Gasser, S., and Raulet, D.H. (2006b) The DNA damage response, immunity and cancer. Semin Cancer Biol 16: 344-347.
21. Geller, T.J., and Condie, D. (1995) A case of protracted coxsackie virus meningoencephalitis in a marginally immunodeficient child treated successfully with intravenous immunoglobulin. J Neurol Sci 129: 131-133.
22. Godeny, E.K., and Gauntt, C.J. (1986) Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis. J Immunol 137: 1695-1702.
23. Godeny, E.K., and Gauntt, C.J. (1987) Murine natural killer cells limit coxsackievirus B3 replication. J Immunol 139: 913-918.
24. Groh, V., Bahram, S., Bauer, S., Herman, A., Beauchamp, M., and Spies, T. (1996) Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 93: 12445-12450.
25. Groh, V., Steinle, A., Bauer, S., and Spies, T. (1998) Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 279: 1737-1740.
26. Guidotti, L.G., and Chisari, F.V. (2001) Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19: 65-91.
27. Henke, A., Nain, M., Stelzner, A., and Gemsa, D. (1991) Induction of cytokine release from human monocytes by coxsackievirus infection. Eur Heart J 12 (Suppl. D): 134-136.
28. Henke, A., Huber, S., Stelzner, A., and Whitton, J.L. (1995) The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 69: 6720-6728.
29. Hertel, N.T., Pedersen, F.K., and Heilmann, C. (1989) Coxsackie B3 virus encephalitis in a patient with agammaglobulinaemia. Eur J Pediatr 148: 642-643.
30. Horwitz, M.S., Krahl, T., Fine, C., Lee, J., and Sarvetnick, N. (1999) Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon. J Virol 73: 1756-1766.
31. Horwitz, M.S., La Cava, A., Fine, C., Rodriguez, E., Ilic, A., and Sarvetnick, N. (2000) Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med 6: 693-697.
32. Huber, S.A., Sartini, D., and Exley, M. (2002) Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: Role for CD4(+) Th1 cells. J Virol 76: 10785-10790.
33. Hultcrantz, M., Huhn, M.H., Wolf, M., Olsson, A., Jacobson, S., Williams, B.R., et al. (2007) Interferons induce an antiviral state in human pancreatic islet cells. Virology 367: 92-101.
34. Hyoty, H., and Taylor, K.W. (2002) The role of viruses in human diabetes. Diabetologia 45: 1353-1361.
35. de Jong, A.S., Visch, H.J., de Mattia, F., van Dommelen, M.M., Swarts, H.G., Luyten, T., et al. (2006) The coxsackievirus 2B protein increases efflux of ions from the endoplasmic reticulum and Golgi, thereby inhibiting protein trafficking through the Golgi. J Biol Chem 281: 14144-14150.
36. Kanda, T., Tanaka, T., Sekiguchi, K., Seta, Y., Kurimoto, M., Wilson McManus, J.E., etal. (2000) Effect of interleukin-18 on viral myocarditis: Enhancement of interferon- gamma and natural killer cell activity. J Mol Cell Cardiol 32: 2163-2171.
37. Kandolf, R., and Hofschneider, P.H. (1985) Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: Full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci USA 82: 4818-4822.
38. Kirwan, S.E., and Burshtyn, D.N. (2007) Regulation of natural killer cell activity. Curr Opin Immunol 19: 46-54.
39. Kishimoto, C., Kuroki, Y., Kurokawa, M., and Ohiai, H. (1997) Lymphokine activated killer cells in murine coxsackievirus B3 myocarditis. Basic Res Cardiol 92: 402-409.
40. Lanier, L.L. (2005a) NK cell recognition. Annu Rev Immunol 23: 225-274.
41. Lanier, L.L. (2005b) NKG2D in innate and adaptive immunity. Adv Exp Med Biol 560: 51-56.
42. Lee, N., Goodlett, D.R., Ishitani, A., Marquardt, H., and Geraghty, D.E. (1998) HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 160: 4951-4960.
43. Lodoen, M.B., and Lanier, L.L. (2006) Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 18: 391-398.
44. Lodoen, M.B., Abenes, G., Umamoto, S., Houchins, J.P., Liu, F., and Lanier, L.L. (2004) The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J Exp Med 200: 1075-1081.
45. Loh, P.C., Oie, H.K., and Ratnayake, R.M. (1970) Accelerated cytopathology in HeLa cells induced by reovirus and cycloheximide. Infect Immun 2: 705-712.
46. Loh, J., Chu, D.T., O'Guin, A.K., Yokoyama, W.M., and Virgin, H.W.T. (2005) Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J Virol 79: 661-667.
47. Mena, I., Perry, C.M., Harkins, S., Rodriguez, F., Gebhard, J., and Whitton, J.L. (1999) The role of B lymphocytes in coxsackievirus B3 infection. Am J Pathol 155: 1205-1215.
48. Pallansch, M., and Roos, R. (2007) Enteroviruses: Polioviruses, Coxsackieviruses, echoviruses, and newer enteroviruses. In Fields Virology. Knipe, D.M. (ed.). Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins, pp. 839-894.
49. Pauschinger, M., Doerner, A., Kuehl, U., Schwimmbeck, P.L., Poller, W., Kandolf, R., and Schultheiss, H.P. (1999) Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99: 889-895.
50. Potvin, D.M., Metzger, D.W., Lee, W.T., Collins, D.N., and Ramsingh, A.I. (2003) Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4. J Virol 77: 8272-8279.
51. Ramsingh, A.I., Lee, W.T., Collins, D.N., and Armstrong, L.E. (1999) T cells contribute to disease severity during coxsackievirus B4 infection. J Virol 73: 3080-3086.
52. Regunathan, J., Chen, Y., Wang, D., and Malarkannan, S. (2005) NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors. Blood 105: 233-240.
53. Roivainen, M. (2006) Enteroviruses: New findings on the role of enteroviruses in type 1 diabetes. Int J Biochem Cell Biol 38: 721-725.
54. Sato, K., Hida, S., Takayanagi, H., Yokochi, T., Kayagaki, N., Takeda, K., etal. (2001) Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta. Eur J Immunol 31: 3138-3146.
55. Schroder, K., Hertzog, P.J., Ravasi, T., and Hume, D.A. (2004) Interferon-gamma: An overview of signals, mechanisms and functions. J Leukoc Biol 75: 163-189.
56. Slifka, M.K., Pagarigan, R., Mena, I., Feuer, R., and Whitton, J.L. (2001) Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. J Virol 75: 2377-2387.
57. Tam, P.E. (2006) Coxsackievirus myocarditis: Interplay between virus and host in the pathogenesis of heart disease. Viral Immunol 19: 133-146.
58. Tracy, S., Chapman, N.M., Drescher, K.M., Kono, K., and Tapprich, W. (2006) Evolution of virulence in picornaviruses. Curr Top Microbiol Immunol 299: 193-209.
59. Tscherne, J.S., and Pestka, S. (1975) Inhibition of protein synthesis in intact HeLa cells. Antimicrob Agents Chemother 8: 479-487.
60. Vales-Gomez, M., Reyburn, H.T., Erskine, R.A., Lopez-Botet, M., and Strominger, J.L. (1999) Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J 18: 4250-4260.
61. Vella, C., and Festenstein, H. (1992) Coxsackievirus B4 infection of the mouse pancreas: The role of natural killer cells in the control of virus replication and resistance to infection. J Gen Virol 73: 1379-1386.
62. Vitale, M., Della Chiesa, M., Carlomagno, S., Pende, D., Arico, M., Moretta, L., and Moretta, A. (2005) NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 106: 566-571.
63. Vreugdenhil, G.R., Wijnands, P.G., Netea, M.G., van der Meer, J.W., Melchers, W.J., and Galama, J.M. (2000) Enterovirus-induced production of pro-inflammatory and T-helper cytokines by human leukocytes. Cytokine 12: 1793-1796.
64. Welte, S.A., Sinzger, C., Lutz, S.Z., Singh-Jasuja, H., Sampaio, K.L., Eknigk, U., etal. (2003) Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol 33: 194-203.
65. Wessely, R., Klingel, K., Knowlton, K.U., and Kandolf, R. (2001) Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: Implications for mortality and early viral replication. Circulation 103: 756-761.
66. Whitton, J.L., and Feuer, R. (2004) Myocarditis, microbes and autoimmunity. Autoimmunity 37: 375-386.
67. Whitton, J.L., Cornell, C.T., and Feuer, R. (2005) Host and virus determinants of picornavirus pathogenesis and tropism. Nat Rev Microbiol 3: 765-776.
68. Zanone, M.M., Favaro, E., Conaldi, P.G., Greening, J., Bottelli, A., Perin, P.C., et al. (2003) Persistent infection of human microvascular endothelial cells by coxsackie B viruses induces increased expression of adhesion molecules. J Immunol 171: 438-446.